Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
मुख्य लेखक: | Tear, L |
---|---|
अन्य लेखक: | Faulkner, S |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
2018
|
विषय: |
समान संसाधन
-
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
द्वारा: T Mortezazadeh, और अन्य
प्रकाशित: (2020-02-01) -
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
द्वारा: Zahra Sahraei, और अन्य
प्रकाशित: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
द्वारा: Marco Moscatelli, और अन्य
प्रकाशित: (2023-10-01) -
Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
द्वारा: Caterina Beatrice Monti, और अन्य
प्रकाशित: (2020-04-01) -
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
द्वारा: Simona Bussi, और अन्य
प्रकाशित: (2020-02-01)